Evaluating Bone Metabolism In Asthmatic Cases Using Inhaled Steroids

作者: Secil Aydinoz , Tolga Unsur , Mustafa Gultepe , Halit Ozkaya , Ismail Gocmen

DOI:

关键词: Bone mineralAsthmaN-terminal telopeptideInternal medicineBone densityHydroxyprolineEndocrinologyPrepubertal stageMedicineBone remodelingPathogenesis

摘要: Background: Bronchial asthma is a chronic inflammatory disease in which eosinophils and different cells play major role pathogenesis, characterized by increased bronchial sensitivity of the airways. Topical steroids had been used to avoid long-term side effects systemic asthma. The inhaled corticosteroids may be explained combined many factors. Objective: This study was performed investigate on bone mineralization also density. Methods: Ninety-seven children divided into three groups, diagnosed with followed up 2002 2003 at GATA Haydarpasa Teaching Hospital were included study. Bone remodeling destruction markers examine metabolism. Results: Comparisons between groups among all revealed no statistical differences specific alkaline phosphatase (bALP), hydroxyproline (HP), carboxy-terminal telopeptide type1 collagen (ICTP), calcium-creatinine ratio (Ca/GF), calcium (Ca) phosphor (P) levels. Analysis that mineral density (BMD) scores significantly higher pubertal stage cases compared those prepubertal stage.

参考文章(27)
Søren Pedersen, John Warner, Ulrich Wahn, Doris Staab, Muriel Le Bourgeois, Elisabeth Van Essen-Zandvliet, Sujata Arora, Stanley J Szefler, Pediatric Study Group, Growth, systemic safety, and efficacy during 1 year of asthma treatment with different beclomethasone dipropionate formulations: an open-label, randomized comparison of extrafine and conventional aerosols in children. Pediatrics. ,vol. 109, ,(2002) , 10.1542/PEDS.109.6.E92
G E Packe, J G Douglas, A F McDonald, S P Robins, D M Reid, Bone density in asthmatic patients taking high dose inhaled beclomethasone dipropionate and intermittent systemic corticosteroids. Thorax. ,vol. 47, pp. 414- 417 ,(1992) , 10.1136/THX.47.6.414
Gail G. Shapiro, MANAGEMENT OF PEDIATRIC ASTHMA: Care by the Specialist Immunology and Allergy Clinics of North America. ,vol. 18, pp. 1- 23 ,(1998) , 10.1016/S0889-8561(05)70343-X
JEAN BOUSQUET, PETER K. JEFFERY, WILLIAM W. BUSSE, MALCOLM JOHNSON, ANTONIO M. VIGNOLA, Asthma. From bronchoconstriction to airways inflammation and remodeling. American Journal of Respiratory and Critical Care Medicine. ,vol. 161, pp. 1720- 1745 ,(2000) , 10.1164/AJRCCM.161.5.9903102
J.C.M. Hoekx, G. Hedlin, W. Pedersen, R. Sorva, K. Hollingworth, J. Efthimiou, Fluticasone propionate compared with budesonide: a double-blind trial in asthmatic children using powder devices at a dosage of 400 microg x day(-1) European Respiratory Journal. ,vol. 9, pp. 2263- 2272 ,(1996) , 10.1183/09031936.96.09112263
Russell J. Hopp, Janice A. Degan, James Phelan, Joan Lappe, G. Chris Gallagher, Cross-sectional study of bone density in asthmatic children Pediatric Pulmonology. ,vol. 20, pp. 189- 192 ,(1995) , 10.1002/PPUL.1950200311
Allen D. Adinoff, J. Roger Hollister, Steroid-Induced Fractures and Bone Loss in Patients with Asthma The New England Journal of Medicine. ,vol. 309, pp. 265- 268 ,(1983) , 10.1056/NEJM198308043090502
J G Douglas, S P Robins, G E Packe, O Robb, D M Reid, Bone density in asthmatic patients taking inhaled corticosteroids: comparison of budesonide and beclomethasone dipropionate. Journal of The Royal College of Physicians of London. ,vol. 30, pp. 128- 132 ,(1996)
Anne-Lise Carrié Fässler, Jean-Philippe Bonjour, Osteoporosis as a Pediatric Problem Pediatric Clinics of North America. ,vol. 42, pp. 811- 824 ,(1995) , 10.1016/S0031-3955(16)39018-6
Søren Pedersen, Ove Ramsgaard Hansen, Budesonide treatment of moderate and severe asthma in children: A dose-response study The Journal of Allergy and Clinical Immunology. ,vol. 95, pp. 29- 33 ,(1995) , 10.1016/S0091-6749(95)70149-4